Advertisement

Search Results

Advertisement



Your search for Linda J. Burns, MD matches 12 pages

Showing 1 - 12


hematologic malignancies

Linda J. Burns, MD, on a Phase II Study of ACE-536 in Beta-Thalassemia

2014 ASH President Linda J. Burns, MD, of the University of Minnesota, offers her thoughts on abstract 53, “ACE-536 Increases Hemoglobin and Decreases Transfusion Burden and Serum Ferritin in Adults With Beta-Thalassemia: Preliminary Results From a Phase II Study,” presented by Antonio G. Piga, MD.

leukemia

Linda J. Burns, MD, on CAR T-Cell Therapy in ALL

2014 ASH President Linda J. Burns, MD, of the University of Minnesota, offers her thoughts on abstract 380, “T Cells Engineered With a Chimeric Antigen Receptor (CAR) Targeting CD19 (CTL019) Have Long-Term Persistence and Induce Durable Remissions in Children with Relapsed, Refractory ALL,”...

leukemia

Linda J. Burns, MD, on the BLAST Study

2014 ASH President Linda J. Burns, MD, of the University of Minnesota, offers her thoughts on abstract 379, “BLAST: A Confirmatory, Single-Arm, Phase II Study of Blinatumomab, a Bispecific T-Cell Engager (BiTE) Antibody Construct, in Patients with Minimal Residual Disease B-Precursor Acute...

American Society of Hematology Elects New Officers

The American Society of Hematology announced the election of three new members to its Executive Committee, the governing body of the organization, for terms to begin in January 2012. Linda J. Burns, MD, will serve a 1-year term as Vice President, followed by successive terms as President-Elect and...

American Society of Hematology Elects New Leadership

The American Society of Hematology (ASH) recently announced the election of four new members to its Executive Committee, the governing body of the organization, for terms to begin in January 2013. At the same time, ASH President-elect and Vice President will begin their tenures as ASH President and ...

hematologic malignancies

ASH Awards Bridge Grants to 15 Investigators

The American Society of Hematology (ASH) recently announced the names of 15 researchers (see sidebar on page 15) who will receive interim support from the Society for hematology research proposals. These proposals earned high scores but could not be funded by the National Institutes of Health (NIH) ...

SIDEBAR: Statement From ASH President Linda J. Burns, MD, on Release of Medicare Physician Payment Data

The Centers for Medicare & Medicaid Services has released a large and complex set of data about the number and type of health-care services that individual physicians and certain other health-care professionals delivered in 2012, and the amount Medicare paid them for those services. The data,...

Statement from ASH President Linda J. Burns, MD,  on Release of Sunshine Act Data

The Centers for Medicare & Medicaid Services (CMS) has released a large set of data about the payments physicians and teaching hospitals received from pharmaceutical and medical device companies from August 1 to December 31, 2013. This public disclosure, mandated under a provision of the...

ASH Awards New Bridge Grants to Help Alleviate Pain of Federal Funding Cuts

In November, the American Society of Hematology (ASH) announced the names of seven recipients of its Bridge Grant awards. These 1-year, $150,000 awards provide critical interim support for hematology research proposals that, despite earning high scores, could not be funded by the National...

hematologic malignancies

The American Society of Hematology Elects New Leadership

The American Society of Hematology (ASH) recently announced the election of four new members to its Executive Committee, the governing body of the organization, for terms beginning after the 2014 ASH Annual Meeting, which will be held December 6–9 in San Francisco. Kenneth C. Anderson, MD, will...

hematologic malignancies
global cancer care

ASH Pairs Hematologists From Developing and Developed Nations for Global Training Program

The American Society of Hematology (ASH) recently announced the 20 hematologists and other medical professionals selected to participate in the 2014 ASH Visitor Training Program. This program provides talented hematologists, scientists, and laboratory staff from developing countries the opportunity ...

hematologic malignancies

ASH Honors Senator Barbara Mikulski and Patient Advocate Kathy Giusti

The American Society of Hematology (ASH) recognized Senator Barbara Mikulski (D-MD) and Kathy Giusti, Founder of the Multiple Myeloma Research Foundation, with awards for their outstanding support and advocacy for biomedical research and the practice of hematology at the 56th ASH Annual Meeting in...

Advertisement

Advertisement



;
Advertisement